ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Minaris Advanced Therapies
The role supports the manufacture of master and working cell banks and the production of cell and gene therapy products in a cGMP environment. Responsibilities include aseptic technique, equipment operation, material preparation, documentation, and compliance with regulatory standards.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
501-1000 employees
Founded
2025
Minaris Advanced Therapies is a contract development and manufacturing organization (CDMO) focused on end-to-end manufacturing and advanced testing for cell and gene therapies. They provide GMP manufacturing, analytical and quality testing services across development through commercial supply, supported by a global network of facilities. With 7,500+ GMP batches and roughly 40 years of testing experience, Minaris positions itself as an experienced partner for biotech and pharma companies advancing cell and gene therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Minaris Advanced Therapies.
Minaris Advanced Therapies didn’t post a salary, so this is our estimate from similar listings.
4% above the average for this role